Le Lézard
Classified in: Science and technology, Business
Subjects: FNC, PDT, PER, ACC

Delta Capita Group Secures an Investment of $50m and Access to Over $100m Transaction Capital From Prytek Holdings


LONDON, March 25, 2020 /PRNewswire/ -- Delta Capita Group, a global consulting, solutions and managed services provider, has secured a $50m equity investment from Prytek Holdings and gained access to over $100m of capital for future acquisitions and funding for client transactions. The investment enables Delta Capita to further expand as one of Europe's leading service providers and fintech technology hubs.

Prytek, the multinational corporation headquartered in Singapore, focuses on technology investments and operations-as-a-service companies, with a $300m diverse portfolio across fintech, edutech, artificial intelligence, cyber security and human resources. Following this transaction, Delta Capita will become the financial services arm of Prytek, bringing a range of innovation and technology to its clients.

Prytek's Managing Partner, Andrey Yahsunky says, "Delta Capita has a unique combination of experience in Financial Services and technology innovation capability allowing it to offer outstanding managed services and solutions to its clients. Delta Capita will now benefit from access to the 35 innovative technology companies across the Prytek Group."

Delta Capita's CEO Joe Channer says, "Access to Prytek's capital and growing portfolio, provides further leverage for Delta Capita and its growth as one of Europe's largest fintech solutions and service providers."

Delta Capita has recently been recognised by the Financial Times as one of the fastest growing businesses for 2020. This announcement follows the recent appointments of a number of high profile industry leaders including:

David Long (Board Member)
Philip Freeborn (Head of Pricing and Risk Services)
Gary McClure (Head of KYC Services) and
Gary Bullock (Head of Post Trade Services)

 


These press releases may also interest you

at 09:17
The following issues have been halted by CIRO Company: Medicus Pharma Ltd. TSX-Venture Symbol: MDCX  All Issues: Yes Reason: Pending News Halt Time (ET): 9:09 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a...

at 09:17
Risk3sixty, a leading cybersecurity technology and consulting firm, announced today that it has been named a Pacesetter Award winner by the Atlanta Business Chronicle for a sixth consecutive year. The Pacesetter Awards celebrate the 100...

at 09:15
via IBN...

at 09:15
The Seattle Kraken today announced new multi-year agreements with TEGNA and Prime Video to offer more options for fans to watch their games throughout the Pacific Northwest....

at 09:15
Thirty Madison, the specialty telemedicine company operating Keeps, Cove, and Nurx, today announced a partnership with Talkspace, a  leading online behavioral health company, to expand comprehensive mental health offerings for more than half a...

at 09:15
RevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today it has successfully closed its first seed funding round, raising $16.5 million to propel its mission to develop and...



News published on and distributed by: